India's Dr Reddy's gains on Coya deal for neurological disease treatment

Coya Therapeutics

07/12/2023 05:03

** Shares of Dr Reddy's Laboratories  REDY.NS  gain 2.1% to
5,849.90 rupees, their best intraday pct gain since Nov 16
    ** The Indian pharma co said on Wednesday that it got into
agreement with Coya Therapeutics  COYA.O  for the latter's
experimental therapy to treat a rare neurological disease 
    ** Dr Reddy's will obtain commercialization rights in the
U.S. and some other countries 
    ** About 272,400 shares change hands vs 30-day avg of
386,936 shares
    ** REDY shares up 37% YTD vs a 29% jump in Nifty pharma
 .NIPHARM 

 (Reporting by Sethuraman NR in Bengaluru)
 ((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))